BioCentury
ARTICLE | Company News

Allergan to acquire botulinum neurotoxin play Bonti

September 21, 2018 4:37 PM UTC

Allergan plc (NYSE:AGN) will acquire Bonti Inc. (Newport Beach, Calif.) for $195 million up front. Bonti shareholders are also eligible for undisclosed commercial milestone payments. Allergan and Bonti declined to disclose details.

In May, Allergan CEO Brent Saunders said the company would divest its women's health and anti-infectives businesses to focus on gastrointestinal and CNS diseases, medical aesthetics and eye care...

BCIQ Company Profiles

Allergan Inc.

Bonti Inc.